Posts

Showing posts with the label Neuropathic Pain competitive landscape

Neuropathic Pain – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Neuropathic pain (NP) arises from damage to the somatosensory nervous system due to a lesion or illness. It can be spontaneous or induced, manifesting as hyperalgesia—an intensified response to painful stimuli—or allodynia, where nonpainful stimuli become painful. The condition is often linked to a history of nervous system disease or injury, leading to a neuroanatomically plausible distribution of pain. Neuropathic pain diagnosing involves identifying sensory symptoms that align with the affected nervous system's territory, including negative symptoms (such as diminished sensation) and positive symptoms (like hyperalgesia or allodynia). Neuropathic pain significantly contributes to the global burden of illness. It can present as the primary symptom, as seen in postherpetic neuralgia, or affect specific individuals, such as those with chemotherapy-induced peripheral neuropathies. Despite the varied symptoms and indicators among individuals with the same underlying cause, neurop...